The global melatonin market is expected to experience significant growth, exceeding US$ 217.9 million by 2033. This growth can be attributed to the increasing popularity of dietary supplements. It is likely to expand at 8.2% CAGR during 2023 to 2033.
Growing awareness among consumers about the benefits of melatonin supplements is driving demand for these products. Melatonin is increasingly recognized as a safe and effective way to improve sleep quality and regulate sleep patterns. Consumers are looking for natural alternatives to pharmaceutical sleep aids.
Melatonin has traditionally been used for improving sleep quality. Several studies suggest that it might have potential benefits in preventing age-related diseases. These include Type 2 diabetes, cardiovascular and neurodegenerative diseases, and cancer, all of which are associated with oxidative stress.
This provides an opportunity for manufacturers to explore new markets. They are also developing innovative products that cater to a wide range of health needs. Research is required to validate the precise efficacy of melatonin in preventing these diseases.
One of the prominent trends is increasing demand for sleep aids and supplements, owing to a hyperactive urban lifestyle. Rising prevalence of sleep related issues such as insomnia and jet lag are leading customers to adopt melatonin as a natural solution.
Another key driver of the melatonin market is the expansion of distribution channels. With the rise of e-commerce platforms and direct-to-consumer companies, melatonin supplements are more accessible than ever before.
Consumers can easily purchase these products online and have them delivered straight to their door. Convenience and greater accessibility has led to higher demand for melatonin among certain demographics.
Besides its accessibility, the development of novel products is also driving growth in the melatonin market. Companies are exploring different formulations, flavors, and delivery methods to make their products more appealing to consumers. For instance, various companies are developing melatonin gummies, which are a fun and innovative way to take the supplement.
Key Trends Listed by Future Market Insights (FMI):
| Attributes | Key Insights |
|---|---|
| Estimated Global Melatonin Market Size (2023E) | US$ 98.5 million |
| Projected Melatonin Market Value (2033F) | US$ 217.5 million |
| Value-based CAGR (2023 to 2033) | 8.2% |
| Top 3 Countries’ Value | US$ 102.3 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Market Statistics | Details |
|---|---|
| Jan to Jun (H1), 2021 (A) | 3.5% |
| Jul to Dec (H2), 2021 (A) | 4.1% |
| Jan to Jun (H1), 2022 Projected (P) | 4.2% |
| Jan to Jun (H1), 2022 Outlook (O) | 3.9% |
| Jul to Dec (H2), 2022 Outlook (O) | 5.2% |
| Jul to Dec (H2), 2022 Projected (P) | 4.9% |
| Jan to Jun (H1), 2023 Projected (P) | 6.5% |
| BPS Change: H1, 2022 (O) to H1, 2022 (P) | 30 |
| BPS Change: H1, 2022 (O) to H1, 2021 (A) | 37 |
| BPS Change: H2, 2022 (O) to H2, 2022 (P) | -30 |
| BPS Change: H2, 2022 (O) to H2, 2022 (A) | 107 |
According to Future Market Insights (FMI), the melatonin market globally grew at a decent rate over the last 4 years, and is expected to reach US$ 98.5 million by 2023-end. It is anticipated to reach a market valuation of US$ 217.9 million by 2033.
Growing working population has become one of the major drivers of the melatonin market on a global scale, mainly due to the arrangement of urban lifestyles. This has led to consumers spending more on nutritional products, resulting in the demand for dietary supplements growing in urban demographics.
It has also been observed that there is growing demand for plant-based and vegan products. It will likely lead to increased demand for plant-based melatonin, as well.
Traditional melatonin supplements are usually derived from animal sources such as cow or pig brains. However, plant-based melatonin is produced using plant sources such as rice, oats, or algae. This makes it a vegan and vegetarian-friendly alternative.
For instance, in May 2022, Nutraland Inc. has launched natural melatonin derived from plant-based treatment types named SOMNATURAL which can replace the use of synthetic melatonin in dietary supplements.
Similarly, in August 2019, Natrol LLC launched a new product - Natrol Kids Melatonin. This new offering is designed to address the growing demand for safe, effective, and non-habit-forming sleep aids for children.
This strategic move is expected to bolster the company's position in the highly competitive sleep supplement industry. It is anticipated to ultimately lead to increased revenue and growth opportunities.
Principal Consultant
Dietary Supplements Market:
| Attributes | Dietary Supplements Market |
|---|---|
| CAGR (2023 to 2033) | 8.0% |
| Market Value (2033) | US$ 350.9 billion |
| Growth Factor | With the rise in chronic diseases and health issues, there has been growing importance on maintaining good health, which has led to an increase in demand for dietary supplements. |
| Opportunity | The development of new and innovative delivery methods for supplements, such as gummies and powders, is creating new opportunities for growth in the market. |
| Key Trends | The sports nutrition segment is experiencing significant growth due to the increasing interest in fitness and healthy lifestyles among consumers. |
Green Tea Supplements Market:
| Attributes | Green Tea Supplements Market |
|---|---|
| CAGR (2023 to 2033) | 6.1% |
| Market Value (2033) | US$ 10.3 billion |
| Growth Factor | As consumers become more health-conscious, there is a growing demand for natural and organic supplements. Green tea supplements are well-positioned to benefit from this trend. |
| Opportunity | Ongoing research and development are expected to lead to the development of new products with improved efficacy and safety, creating opportunities for growth in the market. |
| Key Trends | There is a growing trend towards the use of natural and herbal supplements as people seek alternatives to conventional medications. |
Collagen Supplements Market:
| Attributes | Collagen Supplements Market |
|---|---|
| CAGR (2023 to 2033) | 6.4% |
| Market Value (2033) | US$ 2.8 billion |
| Growth Factor | Increasing awareness about the health benefits of collagen supplements, such as improving skin health and joint mobility. |
| Opportunity | Increasing demand for collagen supplements in the sports and fitness industry for muscle repair and recovery. |
| Key Trends | Growing demand for collagen supplements among the aging population to maintain skin elasticity and prevent joint degeneration. |
| Region | North America |
|---|---|
| Country | United States |
| CAGR | 6.6% |
| BPS Analysis | -74.0 |
| Market Value (2033) | US$ 64.7 million |
| Region | Europe |
|---|---|
| Country | United Kingdom |
| CAGR | 6.7% |
| BPS Analysis | -62.7 |
| Market Value (2033) | US$ 3.3 million |
| Region | Asia Pacific |
|---|---|
| Country | China |
| CAGR | 10.0% |
| BPS Analysis | 193 |
| Market Value (2033) | US$ 27.2 million |
| Region | Asia Pacific |
|---|---|
| Country | India |
| CAGR | 10.4% |
| BPS Analysis | -238.9 |
| Market Value (2033) | US$ 10.1 million |
| Region | Asia Pacific |
|---|---|
| Country | Japan |
| CAGR | 7.9% |
| BPS Analysis | -151.2 |
| Market Value (2033) | US$ 2.8 million |
Increasing Demand from Medical Industry to Treat Insomnia Driving Market Growth
As per the Future Market Insights (FMI) analysis, the United States market for melatonin is expected to attain a market size of US$ 64.7 million by 2033. It is likely to exhibit a CAGR of 6.6% from 2023 to 2033.
The melatonin market in the United States is poised to witness remarkable growth. It is expected to have a dominant position in the North American region. Rising demand for melatonin in the medical industry and the increasing prevalence of insomnia will drive demand.
A report by American Psychiatric Association, around 30% of high school kids receive over 8 hours of sleep on an average academic night, while over 30% of adults sleep for a minimum of six hours each night. According to statistics, 35% of Americans say their sleep is "poor" or "only fair." Over 50 million Americans suffer from persistent sleep difficulties.
Besides this, the United States is also home to a few of the prominent producers of melatonin, including Pfizer, Natrol, LLC (an Aurobindo company), Nature’s Bounty, and Biotics Research Corporation.
These companies have established distribution networks and strong brand recognition. It enables them to efficiently meet the growing demand for melatonin supplements in the market.
Owing to their significant investments in research and development, these companies are continuously introducing innovative products. These factors further boost market growth in the country.
Growing Awareness About the Benefits of Melatonin Supplements Boosting Sales
China’s melatonin market is anticipated to expand at a CAGR of 10.0% from 2023 to 2033. It is likely to reach a market size of US$ 27.2 million by 2033.
According to the National Library of Medicines, about 83.81% of the 100,000 respondents in 2018 reported having a sleep disorder of some kind. Due to the high social pressure and competition for the best educational resources, sleep disorders in Chinese teenagers are frequent. These include inadequate sleep time, abnormal sleep patterns, poor sleep quality, and daytime tiredness.
This demographic is more susceptible to sleep-related issues, further boosting the demand for melatonin supplements. Increasing adoption of a healthy lifestyle, consumers are increasingly turning to melatonin supplements to improve sleep quality and overall health.
These factors, coupled with the growing availability of melatonin supplements in various distribution channels. These factors are expected to drive the market growth of melatonin in China.
Launch of High-Quality Dietary Supplements by Key Players Pushing Demand
The Indian melatonin market is anticipated to achieve a CAGR of 10.4% during 2023 to 2033. It is likely to result in a market size of US$ 10.1 million by 2033.
International companies, such as Swisse Wellness, are launching their products in India. They expect to capitalize on the growing demand for dietary supplements and wellness products in the country.
For instance, in September 2022, Australia's premier brand for health, wellness, and beauty nutrition, Swisse, has recently launched a range of products in India. Among these, the SwisseMe Melatonin Gummies are gaining popularity in the market.
Similarly, Swisse has established partnerships with local distributors to expand its reach in the Indian market. By launching products in India, international companies such as Swisse are looking to tap into the large and growing market potential of the country. It is expected to witness significant growth in the coming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Convenience and Ease of Consumption Pushing Sales of powder/tablet segment
By product type, powder/tablet segment is expected to propel at a CAGR of 8.2% from 2023 to 2033. It is anticipated to reach a market valuation of US$ 211.1 million in the year 2033
Growing demand for dietary supplements has been witnessed among consumers in recent years. This is mainly due to effective marketing campaigns regarding healthy lifestyles.
Rising pollution levels, especially of noise, have also affected the quality of sleep. These factors are expected to remain chronic for consumers over the coming decade, providing sizeable revenue opportunities to manufacturers.
Powder/tablets offer great convenience in production and ease of consumption as compared to liquid forms. They are also more stable and have a long shelf life. These factors make them a preferred choice for manufacturers and consumers alike.
Powder/tablets are easy to transport and store, leading to low transportation and storage costs for companies. Companies that offer wide variety of flavors and the ability to mix and match different supplements are likely to remain popular among consumers.
Synthetic Melatonin Demand to Remain High amid Low Costs and Consistent Quality
Based on nature, demand for synthetic melatonin is expected to remain high during the assessment period. As per Future Market Insights (FMI), it is likely to hold a market share of around 94.4%. The synthetic melatonin segment is projected to reach a valuation of US$ 204.7 million in 2033.
Synthetic melatonin products are experiencing higher sales over natural ones due to various factors. It includes standardized and consistent doses, long shelf life, and low production costs. These factors make them more affordable for consumers. Synthetic melatonin is easy to manufacture and has few regulatory hurdles compared to natural melatonin. It is derived from animal sources and requires more complex extraction and purification processes.
Growing Self-care Trends to Push Sales of Dietary Supplements
By treatment type, dietary supplements segment of the melatonin market is anticipated to expand at a CAGR of 8.3% between 2023 and 2033. It is anticipated to reach a value of US$ 172.4 million by the end of the forecast period.
There is a growing trend of self-care and self-management of health, with individuals seeking more control over their well-being. This trend is driving the demand for dietary supplements, which can be purchased over the counter and used without a doctor's prescription.
Dietary supplements are often marketed as promoting overall health and wellness, rather than just treating a specific ailment. This broad appeal and the perception of promoting general health are key contributors to popularity. This will likely make dietary supplements a more attractive option for individuals looking to improve their sleep quality and overall health.
Dietary supplements are often seen as a safe and more natural alternative to pharmaceuticals, which might have potential side effects and risks.
Key players are focusing on establishing robust distribution networks and increasing their production capacities to meet the growing demand for melatonin supplements.
These companies are emphasized on the quality and purity of their products to build trust among consumers. They are also establishing partnership with retail chains, pharmacies, and online platform to ensure availability.
Key companies are also collaborated with healthcare providers to sell their products through prescription channels.
For instance,
| Attribute | Details |
|---|---|
| Market Value in 2023 | US$ 98.5 million |
| Market Forecast Value in 2033 | US$ 217.5 million |
| Anticipated Growth Rate (2023 to 2033) | 8.2% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Volume (MT) and Value (US$ million) |
| Key Regions Covered | Latin America; Europe; North America; South Asia; East Asia; Oceania; and MEA |
| Key Countries Covered | Canada, United States, Mexico, Brazil, Chile, Peru, Argentina, Italy, Spain, France, Germany, UK, Netherlands, Belgium, Russia, Nordic, Poland, South Korea, China, India, Malaysia, Thailand, Singapore, Australia, Indonesia, Japan, GCC Countries, Central Africa, New Zealand, South Africa, and others |
| Key Market Segments Covered | Product Type, Nature, Treatment Type, and Region |
| Key Companies Profiled | Robinson Pharma, Inc; Wellona Pharmaceutical; Molekula Group; Ebrator Biochemicals; Neurim Pharmaceuticals Ltd.; Xi’an Gaoyuan; Flamma Group; Sisco Research Laboratories; Superior Supplement Manufacturing; Shaanxi Yuantai Biological; Vita Actives Ltd.; Ankaim Inc; Nutraland USA, Inc.; Spectrum Laboratory Products, Inc. |
The market is valued at US$ 98.5 million in 2023.
The growth potential of the market is 8.2% through 2033.
Synthetic melatonin is likely to hold a substantial market share through 2033.
Robinson Pharma, Inc, Wellona Pharmaceutical, and Molekula Group are the key players.
Key players are focusing on enhancing their distribution channels.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition 3. Market Dynamics 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends By Region 3.5. Forecast Factors - Relevance & Impact 3.6. Key Regulations and Policies 4. Value Chain Analysis 4.1. Operating margins at each node of the supply chain 4.2. List of Active Market Participants 5. Global - Pricing Analysis 5.1. Price Point Assessment by Region 5.1.1. Manufacturer-Level Pricing 5.1.2. Distributor Level Pricing 5.2. Price Point Assessment By Product 5.3. Price Forecast till 2033 6. Global Market Size Value (US$ million) and Volume (MT) Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Size Value (US$ million) and Volume (MT) Analysis, 2018 to 2022 6.2. Current and Future Market Size Value (US$ million) and Volume (MT) Analysis, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ million) and Volume (MT) Analysis By Product Type, 2018 to 2022 7.3. Current and Future Market Size Value (US$ million) and Volume (MT) Analysis and Forecast By Product Type, 2023 to 2033 7.3.1. Powder/Tablets 7.3.2. Liquid 7.4. Market Attractiveness Analysis By Product Type 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Nature 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ million) and Volume (MT) Analysis By Nature, 2018 to 2022 8.3. Current and Future Market Size Value (US$ million) and Volume (MT) Analysis and Forecast By Nature, 2023 to 2033 8.3.1. Natural 8.3.2. Synthetic 8.4. Market Attractiveness Analysis By Nature 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Type 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ million) and Volume (MT) Analysis By Treatment Type, 2018 to 2022 9.3. Current and Future Market Size Value (US$ million) and Volume (MT) Analysis and Forecast By Treatment Type, 2023 to 2033 9.3.1. Dietary Supplements 9.3.2. Pharmaceuticals 9.4. Market Attractiveness Analysis By Treatment Type 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 10.1. Introduction 10.2. Historical Market Size Value (US$ million) and Volume (MT) Analysis By Region, 2018 to 2022 10.3. Current Market Size Value (US$ million) and Volume (MT) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East & Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Introduction 11.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 11.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 11.3.1. By Country 11.3.1.1. USA 11.3.1.2. Canada 11.3.2. By Product Type 11.3.3. By Nature 11.3.4. By Treatment Type 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product Type 11.4.3. By Nature 11.4.4. By Treatment Type 11.5. Key Takeaways 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 12.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America Melatonin 12.3.2. By Product Type 12.3.3. By Nature 12.3.4. By Treatment Type 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. Product Type 12.4.3. By Nature 12.4.4. By Treatment Type 12.5. Key Takeaways 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 13.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. United Kingdom 13.3.1.3. France 13.3.1.4. Italy 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Nordic 13.3.1.8. Russia 13.3.1.9. Poland 13.3.1.10. Rest of Europe Melatonin 13.3.2. By Product Type 13.3.3. By Nature 13.3.4. By Treatment Type 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product Type 13.4.3. By Nature 13.4.4. By Treatment Type 13.5. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 14.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Product Type 14.3.3. By Nature 14.3.4. By Treatment Type 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product Type 14.4.3. By Nature 14.4.4. By Treatment Type 14.5. Key Takeaways 15. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 15.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Malaysia 15.3.1.4. Indonesia 15.3.1.5. Singapore 15.3.1.6. Vietnam 15.3.1.7. Philippines 15.3.1.8. Rest of South Asia Melatonin 15.3.2. By Product Type 15.3.3. By Nature 15.3.4. By Treatment Type 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product Type 15.4.3. By Nature 15.4.4. By Treatment Type 15.5. Key Takeaways 16. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 16.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Product Type 16.3.3. By Nature 16.3.4. By Treatment Type 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product Type 16.4.3. By Nature 16.4.4. By Treatment Type 16.5. Key Takeaways 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022 17.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Turkey 17.3.1.3. Egypt 17.3.1.4. South Africa 17.3.1.5. Rest of Middle East and Africa Melatonin 17.3.2. By Product Type 17.3.3. By Nature 17.3.4. By Treatment Type 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product Type 17.4.3. By Nature 17.4.4. By Treatment Type 17.5. Key Takeaways 18. Country-level Market Analysis, 2023 18.1. USA Market Analysis 18.1.1. By Product Type 18.1.2. By Nature 18.1.3. By Treatment Type 18.2. Canada Market Analysis 18.2.1. By Product Type 18.2.2. By Nature 18.2.3. By Treatment Type 18.3. Brazil Market Analysis 18.3.1. By Product Type 18.3.2. By Nature 18.3.3. By Treatment Type 18.4. Mexico Market Analysis 18.4.1. By Product Type 18.4.2. By Nature 18.4.3. By Treatment Type 18.5. Argentina Market Analysis 18.5.1. By Product Type 18.5.2. By Nature 18.5.3. By Treatment Type 18.6. Germany Market Analysis 18.6.1. By Product Type 18.6.2. By Nature 18.6.3. By Treatment Type 18.7. United Kingdom Market Analysis 18.7.1. By Product Type 18.7.2. By Nature 18.7.3. By Treatment Type 18.8. France Market Analysis 18.8.1. By Product Type 18.8.2. By Nature 18.8.3. By Treatment Type 18.9. Italy Market Analysis 18.9.1. By Product Type 18.9.2. By Nature 18.9.3. By Treatment Type 18.10. Spain Market Analysis 18.10.1. By Product Type 18.10.2. By Nature 18.10.3. By Treatment Type 18.11. Belgium Market Analysis 18.11.1. By Product Type 18.11.2. By Nature 18.11.3. By Treatment Type 18.12. Netherlands Market Analysis 18.12.1. By Product Type 18.12.2. By Nature 18.12.3. By Treatment Type 18.13. Nordic Market Analysis 18.13.1. By Product Type 18.13.2. By Nature 18.13.3. By Treatment Type 18.14. Russia Market Analysis 18.14.1. By Product Type 18.14.2. By Nature 18.14.3. By Treatment Type 18.15. Poland Market Analysis 18.15.1. By Product Type 18.15.2. By Nature 18.15.3. By Treatment Type 18.16. China Market Analysis 18.16.1. By Product Type 18.16.2. By Nature 18.16.3. By Treatment Type 18.17. Japan Market Analysis 18.17.1. By Product Type 18.17.2. By Nature 18.17.3. By Treatment Type 18.18. S Korea Market Analysis 18.18.1. By Product Type 18.18.2. By Nature 18.18.3. By Treatment Type 18.19. India Market Analysis 18.19.1. By Product Type 18.19.2. By Nature 18.19.3. By Treatment Type 18.20. Thailand Market Analysis 18.20.1. By Product Type 18.20.2. By Nature 18.20.3. By Treatment Type 18.21. Malaysia Market Analysis 18.21.1. By Product Type 18.21.2. By Nature 18.21.3. By Treatment Type 18.22. Vietnam Market Analysis 18.22.1. By Product Type 18.22.2. By Nature 18.22.3. By Treatment Type 18.23. Philippines Market Analysis 18.23.1. By Product Type 18.23.2. By Nature 18.23.3. By Treatment Type 18.24. Indonesia Market Analysis 18.24.1. By Product Type 18.24.2. By Nature 18.24.3. By Treatment Type 18.25. Singapore Market Analysis 18.25.1. By Product Type 18.25.2. By Nature 18.25.3. By Treatment Type 18.26. Australia Market Analysis 18.26.1. By Product Type 18.26.2. By Nature 18.26.3. By Treatment Type 18.27. New Zealand Market Analysis 18.27.1. By Product Type 18.27.2. By Nature 18.27.3. By Treatment Type 18.28. GCC Countries Market Analysis 18.28.1. By Product Type 18.28.2. By Nature 18.28.3. By Treatment Type 18.29. Turkey Market Analysis 18.29.1. By Product Type 18.29.2. By Nature 18.29.3. By Treatment Type 18.30. Egypt Market Analysis 18.30.1. By Nature 18.30.2. By Treatment Type 18.31. South Africa Market Analysis 18.31.1. By Product Type 18.31.2. By Nature 18.31.3. By Treatment Type 19. Market Structure Analysis 19.1. Global Competition - a Dashboard View 19.2. Industry Structure Analysis 19.2.1. % tier 1 market players 19.2.2. % tier 2 market players 19.2.3. % tier 3 market players 19.3. Global Market Company Share Analysis 19.3.1. For Tier 1 Market Players, 2023 19.3.2. Company Market Share Analysis of Top 5 Players, By Region 19.4. Key Participants Market Presence (Intensity Mapping) by Region 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Wellona Pharmaceutical 20.3.1.1. Product Portfolio 20.3.1.2. Product Claim 20.3.1.3. Revenue by Market Segments (Product/ channel/Region) 20.3.1.4. Sales Footprint 20.3.1.5. Strategy Overview 20.3.1.5.1. Marketing Strategy 20.3.1.5.2. Product Strategy 20.3.1.5.3. Channel Strategy 20.3.1.6. SWOT Analysis 20.3.2. Molekula Group 20.3.2.1. Product Portfolio 20.3.2.2. Product Claim 20.3.2.3. Revenue by Market Segments (Product/ channel/Region) 20.3.2.4. Sales Footprint 20.3.2.5. Strategy Overview 20.3.2.5.1. Marketing Strategy 20.3.2.5.2. Product Strategy 20.3.2.5.3. Channel Strategy 20.3.2.6. SWOT Analysis 20.3.3. Ebrator Biochemicals 20.3.3.1. Product Portfolio 20.3.3.2. Product Claim 20.3.3.3. Revenue by Market Segments (Product/ channel/Region) 20.3.3.4. Sales Footprint 20.3.3.5. Strategy Overview 20.3.3.5.1. Marketing Strategy 20.3.3.5.2. Product Strategy 20.3.3.5.3. Channel Strategy 20.3.3.6. SWOT Analysis 20.3.4. Neurim Pharmaceuticals Ltd. 20.3.4.1. Product Portfolio 20.3.4.2. Product Claim 20.3.4.3. Revenue by Market Segments (Product/ channel/Region) 20.3.4.4. Sales Footprint 20.3.4.5. Strategy Overview 20.3.4.5.1. Marketing Strategy 20.3.4.5.2. Product Strategy 20.3.4.5.3. Channel Strategy 20.3.4.6. SWOT Analysis 20.3.5. Xi’an Gaoyuan 20.3.5.1. Product Portfolio 20.3.5.2. Product Claim 20.3.5.3. Revenue by Market Segments (Product/ channel/Region) 20.3.5.4. Sales Footprint 20.3.5.5. Strategy Overview 20.3.5.5.1. Marketing Strategy 20.3.5.5.2. Product Strategy 20.3.5.5.3. Channel Strategy 20.3.5.6. SWOT Analysis 20.3.6. Flamma Group 20.3.6.1. Product Portfolio 20.3.6.2. Product Claim 20.3.6.3. Revenue by Market Segments (Product/ channel/Region) 20.3.6.4. Sales Footprint 20.3.6.5. Strategy Overview 20.3.6.5.1. Marketing Strategy 20.3.6.5.2. Product Strategy 20.3.6.5.3. Channel Strategy 20.3.6.6. SWOT Analysis 20.3.7. Sisco Research Laboratories 20.3.7.1. Product Portfolio 20.3.7.2. Product Claim 20.3.7.3. Revenue by Market Segments (Product/ channel/Region) 20.3.7.4. Sales Footprint 20.3.7.5. Strategy Overview 20.3.7.5.1. Marketing Strategy 20.3.7.5.2. Product Strategy 20.3.7.5.3. Channel Strategy 20.3.7.6. SWOT Analysis 20.3.8. Superior Supplement Manufacturing 20.3.8.1. Product Portfolio 20.3.8.2. Product Claim 20.3.8.3. Revenue by Market Segments (Product/ channel/Region) 20.3.8.4. Sales Footprint 20.3.8.5. Strategy Overview 20.3.8.5.1. Marketing Strategy 20.3.8.5.2. Product Strategy 20.3.8.5.3. Channel Strategy 20.3.8.6. SWOT Analysis 20.3.9. Shaanxi Yuantai Biological 20.3.9.1. Product Portfolio 20.3.9.2. Product Claim 20.3.9.3. Revenue by Market Segments (Product/ channel/Region) 20.3.9.4. Sales Footprint 20.3.9.5. Strategy Overview 20.3.9.5.1. Marketing Strategy 20.3.9.5.2. Product Strategy 20.3.9.5.3. Channel Strategy 20.3.9.6. SWOT Analysis 20.3.10. Vita Actives Ltd. 20.3.10.1. Product Portfolio 20.3.10.2. Product Claim 20.3.10.3. Revenue by Market Segments (Product/ channel/Region) 20.3.10.4. Sales Footprint 20.3.10.5. Strategy Overview 20.3.10.5.1. Marketing Strategy 20.3.10.5.2. Product Strategy 20.3.10.5.3. Channel Strategy 20.3.10.6. SWOT Analysis 20.3.11. Ankaim Inc 20.3.11.1. Product Portfolio 20.3.11.2. Product Claim 20.3.11.3. Revenue by Market Segments (Product/ channel/Region) 20.3.11.4. Sales Footprint 20.3.11.5. Strategy Overview 20.3.11.5.1. Marketing Strategy 20.3.11.5.2. Product Strategy 20.3.11.5.3. Channel Strategy 20.3.11.6. SWOT Analysis 20.3.12. Nutraland USA, Inc. 20.3.12.1. Product Portfolio 20.3.12.2. Product Claim 20.3.12.3. Revenue by Market Segments (Product/ channel/Region) 20.3.12.4. Sales Footprint 20.3.12.5. Strategy Overview 20.3.12.5.1. Marketing Strategy 20.3.12.5.2. Product Strategy 20.3.12.5.3. Channel Strategy 20.3.12.6. SWOT Analysis 20.3.13. Spectrum Laboratory Products, Inc. 20.3.13.1. Product Portfolio 20.3.13.2. Product Claim 20.3.13.3. Revenue by Market Segments (Product/ channel/Region) 20.3.13.4. Sales Footprint 20.3.13.5. Strategy Overview 20.3.13.5.1. Marketing Strategy 20.3.13.5.2. Product Strategy 20.3.13.5.3. Channel Strategy 20.3.13.6. SWOT Analysis 20.3.14. Other Players (On Additional Requests) 20.3.14.1. Product Portfolio 20.3.14.2. Product Claim 20.3.14.3. Revenue by Market Segments (Product/ channel/Region) 20.3.14.4. Sales Footprint 20.3.14.5. Strategy Overview 20.3.14.5.1. Marketing Strategy 20.3.14.5.2. Product Strategy 20.3.14.5.3. Channel Strategy 20.3.14.6. SWOT Analysis 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Food and Beverage Insights
View Reports
Melatonin Market
